Literature DB >> 20501662

Identification of novel specific allosteric modulators of the glycine receptor using phage display.

Megan E Tipps1, Jessica E Lawshe, Andrew D Ellington, S John Mihic.   

Abstract

The glycine receptor (GlyR) is a member of the Cys-loop superfamily of ligand-gated ion channels and the major mediator of inhibitory neurotransmission in the spinal cord and brainstem. Many allosteric modulators affect the functioning of members of this superfamily, with some such as benzodiazepines showing great specificity and others such as zinc, alcohols, and volatile anesthetics acting on multiple members. To date, no potent and efficacious allosteric modulator acting specifically at the GlyR has been identified, hindering both experimental characterization of the receptor and development of GlyR-related therapeutics. We used phage display to identify novel peptides that specifically modulate GlyR function. Peptide D12-116 markedly enhanced GlyR currents at low micromolar concentrations but had no effects on the closely related gamma-aminobutyric acid type A receptors. This approach can readily be adapted for use with other channels that currently lack specific allosteric modulators.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20501662      PMCID: PMC2906275          DOI: 10.1074/jbc.M110.130815

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

Review 1.  Phage display technology: clinical applications and recent innovations.

Authors:  Hassan M E Azzazy; W Edward Highsmith
Journal:  Clin Biochem       Date:  2002-09       Impact factor: 3.281

Review 2.  Molecular pharmacology of the glycine receptor chloride channel.

Authors:  Timothy I Webb; Joseph W Lynch
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

3.  Cell line provenance.

Authors:  R Ian Freshney
Journal:  Cytotechnology       Date:  2002-07       Impact factor: 2.058

4.  In vitro selection of peptides acting at a new site of NMDA glutamate receptors.

Authors:  M Li; W Yu; C H Chen; S Cwirla; E Whitehorn; E Tate; R Raab; M Bremer; B Dower
Journal:  Nat Biotechnol       Date:  1996-08       Impact factor: 54.908

5.  Enhancement of homomeric glycine receptor function by long-chain alcohols and anaesthetics.

Authors:  M P Mascia; T K Machu; R A Harris
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

Review 6.  Evolutionary history of the ligand-gated ion-channel superfamily of receptors.

Authors:  M O Ortells; G G Lunt
Journal:  Trends Neurosci       Date:  1995-03       Impact factor: 13.837

7.  Blockade of ethanol-induced potentiation of glycine receptors by a peptide that interferes with Gbetagamma binding.

Authors:  Leonardo Guzman; Gustavo Moraga-Cid; Ariel Avila; Maximiliano Figueroa; Gonzalo E Yevenes; Jorge Fuentealba; Luis G Aguayo
Journal:  J Pharmacol Exp Ther       Date:  2009-09-22       Impact factor: 4.030

8.  Glycine receptors contribute to hypnosis induced by ethanol.

Authors:  Jiang H Ye; Kimberly A Sokol; Urvi Bhavsar
Journal:  Alcohol Clin Exp Res       Date:  2009-03-23       Impact factor: 3.455

9.  Allosteric modulation of the calcium-sensing receptor.

Authors:  Anders A Jensen; Hans Bräuner-Osborne
Journal:  Curr Neuropharmacol       Date:  2007-09       Impact factor: 7.363

10.  High Throughput Techniques for Discovering New Glycine Receptor Modulators and their Binding Sites.

Authors:  Daniel F Gilbert; Robiul Islam; Timothy Lynagh; Joseph W Lynch; Timothy I Webb
Journal:  Front Mol Neurosci       Date:  2009-10-30       Impact factor: 5.639

View more
  14 in total

1.  Allosteric modulation of the glycine receptor activated by agonists differing in efficacy.

Authors:  Nicole-Marie M Farley; S John Mihic
Journal:  Brain Res       Date:  2015-02-24       Impact factor: 3.252

2.  Contaminating levels of zinc found in commonly-used labware and buffers affect glycine receptor currents.

Authors:  Garrett L Cornelison; S John Mihic
Journal:  Brain Res Bull       Date:  2013-10-28       Impact factor: 4.077

Review 3.  Allosteric modulation of glycine receptors.

Authors:  Gonzalo E Yevenes; Hanns Ulrich Zeilhofer
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

4.  Generation of recombinant guinea pig antibody fragments to the human GABAC receptor.

Authors:  Adnan Memic; Veronica V Volgina; Hélène A Gussin; David R Pepperberg; Brian K Kay
Journal:  J Immunol Methods       Date:  2011-02-26       Impact factor: 2.303

5.  A Novel Peptide Restricts Ethanol Modulation of the BK Channel In Vitro and In Vivo.

Authors:  Luisa L Scott; Sangeetha Iyer; Ashley E Philpo; Melva N Avalos; Natalie S Wu; Ted Shi; Brooke A Prakash; Thanh-Tu Nguyen; S John Mihic; Richard W Aldrich; Jonathan T Pierce
Journal:  J Pharmacol Exp Ther       Date:  2018-08-29       Impact factor: 4.030

Review 6.  Application of phage peptide display technology for the study of food allergen epitopes.

Authors:  Xueni Chen; Stephen C Dreskin
Journal:  Mol Nutr Food Res       Date:  2017-02-08       Impact factor: 5.914

7.  Trifluoroacetate is an allosteric modulator with selective actions at the glycine receptor.

Authors:  Megan E Tipps; Sangeetha V Iyer; S John Mihic
Journal:  Neuropharmacology       Date:  2012-04-24       Impact factor: 5.250

8.  Identification and characterization of heptapeptide modulators of the glycine receptor.

Authors:  Garrett L Cornelison; Natasha C Pflanz; Megan E Tipps; S John Mihic
Journal:  Eur J Pharmacol       Date:  2016-03-31       Impact factor: 4.432

9.  Physiological concentrations of zinc reduce taurine-activated GlyR responses to drugs of abuse.

Authors:  Dean Kirson; Garrett L Cornelison; Ashley E Philpo; Jelena Todorovic; S John Mihic
Journal:  Neuropharmacology       Date:  2013-08-21       Impact factor: 5.250

10.  Generation of recombinant antibodies to rat GABAA receptor subunits by affinity selection on synthetic peptides.

Authors:  Sujatha P Koduvayur; Hélène A Gussin; Rajni Parthasarathy; Zengping Hao; Brian K Kay; David R Pepperberg
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.